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RESEARCH NOTE
Association of trans fatty acids with lipids 
and other cardiovascular risk factors in an Indian 
industrial population
Ruby Gupta1* , Ransi Ann Abraham2, Dimple Kondal1, Savita Dhatwalia1, Panniyammakal Jeemon3, 
K. S. Reddy1, D. Prabhakaran1 and Lakshmy Ramakrishnan2
Abstract 
Objective: Trans-fat, an invariable component of industrial fat is considered as one of the major dietary factors 
associated with CVD. Although the use of trans-fat is completely banned in some of the high-income countries where 
the CVD epidemic is declining, it is widely used in LMIC. We aimed to investigate the association of trans fatty acid in 
serum with risk markers of CVD in an industrial population in India. Participants were randomly selected from a study 
conducted in an industrial setting among employees and their family members. Information related to their demo-
graphic profile, anthropometric measurements, oil intake were recorded. Fasting samples were collected and stored 
at − 80 °C for analysis. Their lipid profile and hs CRP were measured and fatty acids analyzed using gas chromatogra-
phy (GC) with flame ionization detector (FID).
Results: Complete data was available for 176 participants. Among trans fatty acids, mono trans fatty acid was signifi-
cant predictor of serum triglycerides [Unadjusted β (95% CI) 22.9 (2.6, 43.2); Adjusted β (95% CI) 20.4 (3.5, 37.3)]. None 
of the other trans fatty acids either individually or in group correlated with any of the biochemical markers studied.
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Introduction
Cardiovascular Disease (CVD) burden is increasing in 
low and middle-income countries [1] in the past two 
decades. Studies imply that consumption of trans fatty 
acids is directly contributing to the twentieth century 
epidemic of cardiovascular disease [2]. Several prospec-
tive epidemiological studies provide strong evidence on 
the association of trans-fat consumption and coronary 
heart disease [3–5]. Adverse effects of trans fatty acids 
are mainly due to their effects on lipid levels, endothe-
lial function and inflammation [6]. The increase in car-
diovascular disease risk in developing countries like India 
is largely due to sociological changes, urbanization and 
socio-economic status that influences pattern of dietary 
fat intake. India is a country with wide variation in food 
habits and trans fatty acids from dietary sources may be 
contributing to increased risk of CVD. In many parts of 
India, hydrogenated vegetable oil in the form of Vanas-
pati are consumed in great quantity which is known to 
have highest content of trans fat. On the other hand, in 
northern India the most commonly used oil is mustard 
oil that is rich in alpha-linoleic acid (18:3, n − 3), a poly-
unsaturated fatty acid. In a recent study, high trans-fat 
content was reported in fried food and snacks [7, 8] as 
well as edible oils from various commercially available 
brands in India [9].
Intake of fats can be best assessed by objectively meas-
uring them in serum/plasma under controlled conditions 
[10]. Recently, WHO has announced an initiative called 
REPLACE to eliminate trans fat completely from the 
world by 2023. To assess the intake of trans fat and the 
gravity of problem caused by trans fat in India we need to 
objectively measure trans fat in blood [11]. To the best of 
our knowledge, information on levels of trans fatty acids 
in plasma/serum are not available from resident Indians. 
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In the present study we estimated serum fatty acid lev-
els in an industrial population from India and evaluated 
its correlation with other risk factors for CVD, like lipids, 
lipoproteins and markers of inflammation.
Main text
Methods
The present study was part of a larger study being under-
taken in an industrial population from Delhi [12]. The 
study was conducted to assess the impact of a risk reduc-
tion programme on risk factor clustering in selected 
industrial population. We randomly selected 200 indi-
viduals from the baseline survey of the main study, 
conducted in an Industry in periphery of New Delhi. Par-
ticipants were industry employees and their family mem-
bers, between the age 20 to 69  years. Individuals who 
reported smoking (more than 10 cig/day), having heart 
disease, stroke, chronic renal failure, thyroid disorder and 
cancer were excluded from the study. Participants with 
diabetes (history or freshly diagnosed) were not included 
in the study. Also, those who reported consuming any 
dietary supplements or medications known to alter 
lipids, on steroids and beta-blockers were excluded.
Data related to their demographic profile, anthropo-
metric measurements, frequency of food intake and type 
of oil use were collected for all the individuals partici-
pating in the study. Blood samples were collected after 
an overnight fast of 10–12  h. Serum was separated and 
stored at − 70  °C for analysis of lipids and fatty acids. 
Total cholesterol was estimated by CHOD-PAP (choles-
terol oxidase/p-aminophenazone) method, triglycerides 
by GPO-PAP (glycerol phosphate oxidase-peroxidase 
aminophenazone) method, HDL-c was estimated by the 
precipitation method using phosphotungstate/magne-
sium precipitation of apolipoprotein B containing lipo-
proteins followed by estimation of cholesterol in the 
supernatant by enzymatic method, using kits from RAN-
DOX. Apo A1, Apo B were estimated by the immuno-
turbidimetry method and hs CRP was estimated by latex 
enhanced agglutination turbidimetry using kits from 
Sentinel Diagnostics (Milan, Italy).
Fatty acid analysis
Esterification of fatty acids in serum was performed using 
method of [13]. 200  µL serum was mixed with 2  mL of 
methanol-toluene (4:1, v/v) containing 0.02 g 21:0/L and 
0.12 g butylated hydroxytoluene/L followed by drop wise 
addition of 200 µL acetyl chloride and heating to 100 °C 
for 1  h. The reaction was stopped by adding 5.0  mL of 
6% potassium carbonate. The sample was centrifuged at 
3000 rpm at 4 °C for 10 min, the toluene layer was sepa-
rated and evaporated under stream of nitrogen. Fatty acid 
methyl esters were re-dissolved in iso-octane and were 
subjected to gas–liquid chromatography. Column used 
was fused silica capillary SP2560, 100 m × 250 µm inter-
nal diameters × 0.20 µm film (Supelco, Bellefonte, Penn-
sylvania). The port temperatures of both the injector and 
the detector were set at 250  °C. The Oven temperature 
was initially set at 170  °C for 2  min and then increased 
10  °C/min until a temperature of 190  °C is reached and 
then held for 1 min. Temperature was then increased at 
the rate 3 °C/min until 220 °C is reached and maintained. 
1  µL sample was used for injection with a split of 10:1. 
The chromatograph was equipped with a flame ioniza-
tion detector. Fatty acid peaks were identified by com-
paring their retention times with those of a standard 
mixture from Supelco (SIGMA-ALDRICH) using soft-
ware WINACDS 7.0 from AIMIL, Nucon Technologies.
Statistical analysis
The distribution of the parameters was assessed graphi-
cally using histograms, q–q plots and Shapiro-Wilks 
lambda test. Data are presented as mean ± SD for nor-
mally distributed and as median (Inter-quartile range) 
for non-normally distributed fatty acids. Individual fatty 
acids were expressed in terms of percentage of total fatty 
acids measured. The strength of relationship between 
lipid profile and various fatty acids were calculated using 
Pearson/Spearman rank correlation whichever appro-
priate. Linear regression was done to assess the strength 
of association of total cholesterol, triglycerides, HDL-c, 
LDL-c, TC/HDL ratio, Apo A1, Apo B and hs CRP (as 
outcomes) with various fatty acids (Independent vari-
ables). The model was also adjusted for age, gender, BMI, 
diet, smoking and alcohol use. The β estimates with 95% 
confidence intervals are reported. All the statistical anal-
ysis was done using STATA 15.1 version (College station, 
Texas, USA).
Trans fatty acids were further grouped as mono trans 
fatty acids: C16:1 t, C 18:1 9t, C 18:1 11t; poly trans fatty 
acids: C 18:2 t, C 18:3 t; total trans fatty acid: mono 
trans + poly trans.
Results
Total 1229 employees were recruited for the main study. 
After screening for the exclusion criteria, 518 individuals 
were found eligible. We randomly selected 200 individu-
als for our study and complete biochemical as well as fatty 
acid profile were available for 176 individuals. The mean 
age of the study population was 47.23 ± 6.0  years and 
were predominantly males (89.2%). The mean Body Mass 
Index (BMI in kg/m2) of the participants was 24.88 ± 3.43 
with a mean waist circumference of 91.50 ± 9.56 cm. 40% 
of the participants were vegetarian, 22% were smokers 
and 35% were current users of alcohol. 9% of the study 
participant had self-reported hypertension. The basic 
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characteristics of the study participants, their biochemi-
cal risk markers are provided in Table 1. The mean per-
cent content of trans fatty acid in the study participants 
were highly skewed as can be seen in Additional file  1: 
Table S1.
Table 2 shows the correlation between trans fatty acids 
with other biochemical risk markers of CVD. Among 
trans fatty acids, mono trans fatty acid was positively 
associated with serum triglycerides (r = 0.166) and 
C16:1 trans with Apo B (r = 0.153) and LDL (r = 0.112). 
C18:2 trans was inversely associated with HDL levels 
in serum (r = − 0.136). The relationship between trans 
fatty acids and lipids and other markers remain the same 
after adjustment with age and gender (data not shown). 
None of the other trans fatty acids either individually or 
in group correlated with any of the biochemical markers 
studied.
On regression analysis (Tables  3, 4, 5), mono trans 
and trans palmitoleic acid significantly predicted high 
triglyceride levels even after adjustment with potential 
confounders [Unadjusted β (95% CI) 22.9 (2.6, 43.2); 
Adjusted β (95% CI) 20.4 (3.5, 37.3) and Unadjusted β 
(95% CI) 26.5 (− 0.9, 53.8); Adjusted β (95% CI) 20.9 (1.1, 
40.7) respectively]. This implies that 1 unit (here % of 
fatty acids) change in mono trans fatty acid is associated 
with an average rise of triglycerides by 20 mg/dL.
Discussion
The diet among Indian population varies considerably 
with geographical location. Unlike western countries 
where majority of the population is dependent on pack-
aged food, Indians are more experimental with their 
indigenous agricultural products. This gives rise to an 
enormous possibility of food categories and types, and 
their fatty acid content assessment is a labor intensive 
task, however, serum fatty acid profile reflects the recent 
intake through diet. Fasting serum/plasma is a preferred 
sample of choice for epidemiological studies to assess 
dietary fatty acid intake, we have assessed the association 
between fatty acids & cardiovascular risk markers in the 
present study.
Evaluation of the effect of C18:2 trans and C18:3 trans 
on cardiovascular risk markers through dietary studies 
was not found in literature. Majority of the studies have 
been conducted in western countries and have evaluated 
effect of C18:1 trans, as the major oil in their diet is mon-
ounsaturated fatty acid.
Table 1 Basic characteristics and  biochemical markers 
of the study participants (n = 176)
BMI, body mass index; IQR, inter quartile range; HDL-c, high-density lipoprotein 
cholesterol; LDL-c, low-density lipoprotein cholesterol; Apo A1, apolipoprotein 
A1; Apo B, apolipoprotein B; hs CRP, high sensitive c-reactive protein
Parameters N (%)/mean 
(SD)/median 
(IQR)
Age in years, mean (sd) 47.2 (6.0)
Gender, males (%) 157 (89.2)
BMI (kg/m2), mean (sd) 24.9 (3.4)
Waist circumference (cm), mean (sd) 91.5 (9.5)
Vegetarian diet, n (%) 71 (40.3)
Ever smokers, n (%) 38 (21.6)
Alcohol use, n (%) 62 (35.2)
Hypertension, n (%) 16 (9.1)
Cholesterol (mg/dL), mean (sd) 194.7 (30.7)
Triglycerides (mg/dL), mean (sd) 139.5 (62.4)
HDL-c (mg/dL), mean (sd) 37.5 (9.3)
Chol/hdl ratio, mean (sd) 5.4 (1.0)
LDL-c (mg/dL), mean (sd) 130.8 (28.7)
Apo  A1 (mg/dL), mean (sd) 125.8 (23.7)
Apo B (mg/dL), mean (sd) 106.9 (20.0)
Hs CRP (mg/L), median (IQR) 1.7 (0.8, 3.8)
Table 2 Correlation coefficient between trans fatty acids with lipids and inflammatory marker
TC, total cholesterol; TG, triglycerides; HDL, high density lipoprotein cholesterol; LDL, low-density lipoprotein cholesterol; 18:1 trans, C 18:1 9t + C 18:1 11t; mono trans 
fatty acids, C16:1 t + C 18:1 9t (Elaidic acid) + C 18:1 11t (Vaccenic acid); poly trans fatty acids, C 18:2 t + C 18:3 t; total trans fatty acid, mono trans + poly trans; Apo A1, 
apolipoprotein A1; Apo B, apolipoprotein B; hs CRP, high sensitive c-reactive protein
Fatty acids TC TG HDL TC/HDL ratio LDL Apo A1 Apo B hs CRP
C18:1 trans − 0.086 0.091 − 0.071 0.003 − 0.143 0.041 − 0.117 − 0.037
C18:2 trans − 0.077 − 0.041 − 0.136 0.095 − 0.041 − 0.111 − 0.066 − 0.073
C18:3 trans − 0.003 0.011 0.088 − 0.112 − 0.008 − 0.078 − 0.036 0.055
Mono trans − 0.014 0.166 − 0.105 0.063 − 0.018 0.013 0.028 − 0.056
Poly trans − 0.037 − 0.009 0.014 − 0.052 − 0.024 − 0.114 − 0.060 0.016
Total trans − 0.038 0.059 − 0.029 − 0.020 − 0.029 − 0.098 − 0.043 − 0.008
C16:1 trans 0.056 0.143 − 0.078 0.082 0.112 − 0.021 0.153 − 0.041
C 18:1 11 trans − 0.099 0.073 − 0.006 − 0.070 − 0.104 − 0.077 − 0.054 − 0.028
C18:1 9 trans − 0.045 0.065 − 0.078 0.040 − 0.107 0.090 − 0.106 − 0.028
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In our study, mono trans fatty acid appears to be inde-
pendently associated with raised triglycerides. The major 
contributor of mono trans are the trans-palmitoleic 
(palmitelaidic), elaidic and vaccenic acid, of which trans 
palmitoleic was the major contributor for significant 
raise in serum triglycerides. The major source of trans-
palmitoleic acid in the study population was milk which 
was reported to be consumed by almost all the partici-
pants. The trans palmitoleic acid has been found to be 
triglycerides lowering by [14]. Association with raised 
triglycerides in our study could be due to hepatic release 
of endogenous triglycerides as a result of excess intake of 
carbohydrate as it is customary in India to consume milk 
& its product in the form of sweet. It is worthwhile to be 
noted that the 95% confidence interval in the regression 
analysis was wide due to small sample size.
In conclusion poly trans and total trans were not found 
to be associated with any of the cardiovascular risk mark-
ers in our study. Mono trans showed significant associa-
tion with triglycerides.
We did not find any association between trans fatty 
acid and risk markers probably due to inadequate sample 
Table 3 Regression analysis of trans fatty acids of C18 series
TC, total cholesterol; TG, triglycerides; HDL, high-density lipoprotein cholesterol; LDL, low-density lipoprotein cholesterol; Apo A1, apolipoprotein A1; Apo B, 
apolipoprotein B; hs CRP, high sensitive c-reactive protein
* Values are significant (p < 0.05)
# Model adjusted with age, sex, bmi, diet, smoking and alcohol use
Fatty acids TC TG HDL TC/HDL LDL Apo A1 Apo B hs CRP
18:1 trans
 β Unadjusted 
(95% CI)
− 8.9 (− 24.3, 6.5) 19.3 (− 12.0, 50.5) − 2.2 (− 6.9, 2.4) 0 (− 0.5, 0.5) − 13.8 (− 29.1, 1.4) 3.3 (− 9.4, 16.0) − 7.9 (− 18.6, 2.7) − 1 (− 5.4, 3.3)
 β Adjusted 
(95% CI)#
− 14.1 (− 38.6, 10.4) 26.2 (− 3.4, 75.8) − 4.3 (− 11.5, 2.9) 0.1 (− 0.7, 0.8) − 21.9 (− 45.8, 2.1) 4.6 (− 15.3, 24.6) − 11.2 (− 28.0, 5.7) − 2.3 (− 9.5, 4.8)
18:2 trans
 β Unadjusted 
(95% CI)
− 5.4 (− 15.9, 5.1) − 5.9 (− 27.2, 15.5) − 2.9 (− 6.1, 0.3) 0.2 (− 0.1, 0.6) − 2.8 (− 13.7, 8.1) − 6.3 (− 15.3, 2.6) − 3.2 (− 10.8, 4.4) − 1.4 (− 4.5, 1.7)
 β Adjusted 
(95% CI)#
− 2.1 (− 6.6, 2.5) 2.0 (− 7.0, 11.0) − 1.0 (− 2.2, 0.2) 0.1 (− 0.0, 0.2) − 1.3 (− 5.9, 3.3) − 1.4 (− 5.0, 2.2) 0.5 (− 2.6, 3.6) − 0.1 (− 0.5, 0.2)
18:3 trans
 β Unadjusted 
(95% CI)
− 0.1 (− 5.7, 5.4) 0.8 (− 10.5, 12.1) 1.0 (− 0.7, 2.7) − 0.1 (− 0.3, 0.0) − 0.3 (− 5.7, 5.2) − 2.2 (− 6.7, 2.3) − 0.9 (− 4.7, 2.9) 0.5 (− 1.0, 2.1)
 β Adjusted 
(95% CI)#
− 1.5 (− 8.9, 6.0) 2.3 (− 12.7, 17.2) 0.8 (− 1.4, 2.9) − 0.1 (− 0.4, 0.1) − 3.2 (− 10.0, 3.6) − 2.6 (− 8.2, 3.0) − 1.8 (− 6.6, 2.9) 0.3 (− 1.7, 2.4)
Table 4 Regression analysis of trans fatty acids in groups
TC, total cholesterol; TG, triglycerides; HDL: high-density lipoprotein cholesterol; LDL, low-density lipoprotein cholesterol; Apo A1, apolipoprotein A1; Apo B, 
apolipoprotein B; hs CRP, high sensitive c-reactive protein
* Values are significant (p < 0.05)
# Model adjusted with age, sex, bmi, diet, smoking and alcohol use
Fatty acids TC TG HDL TC/HDL LDL Apo A1 Apo B hs CRP
Mono trans
 β Unadjusted 
(95% CI)
− 1.0 (− 11.1, 9.2) 22.9 (2.6, 43.2)* − 2.2 (− 5.2, 0.9) 0.1 (− 0.2, 0.5) − 1.2 (− 11.9, 9.4) 0.7 (− 8.1, 9.6) 1.3 (− 6.1, 8.8) − 1.1 (− 4.1, 2.0)
 β Adjusted 
(95% CI)#
− 0.2 (− 9.2, 8.8) 20.4 (3.5, 37.3)* − 0.8 (− 3.3, 1.7) 0 (− 0.2, 0.3) − 4.0 (− 12.6, 4.7) 1.2 (− 5.8, 8.3) − 0.6 (− 6.7, 5.6) − 0.8 (− 3.4, 1.8)
Poly trans
β  Unadjusted 
(95% CI)
− 1.2 (− 5.9, 3.5) − 0.6 (− 10.2, 9.0) 0.1 (− 1.3, 1.6) − 0.1 (− 0.2, 0.1) − 0.7 (− 5.4, 4.0) − 2.8 (− 6.6, 1.0) − 1.2 (− 4.5, 2.0) 0.1 (− 1.2, 1.5)
 β Adjusted 
(95% CI)#
− 2.9 (− 10.7, 4.9) 2.4 (− 13.3, 18.2) 0 (− 2.2, 2.3) − 0.1 (− 0.3, 0.2) − 3.8 (− 11.0, 3.5) − 4.1 (− 10.1, 1.8) − 2.3 (− 7.4, 2.7) 0.1 (− 2.0, 2.3)
Total trans
 β Unadjusted 
(95% CI)
− 1.1 (− 5.2, 3.1) 3.4 (− 5.0, 11.8) − 0.3 (− 1.5, 1.0) 0 (− 0.2, 0.1) − 0.8 (− 5.0, 3.5) − 2.2 (− 5.7, 1.3) − 0.8 (− 3.8, 2.2) − 0.1 (− 1.3, 1.1)
 β Adjusted 
(95% CI)#
− 2.9 (− 12.8, 7.1) 9.5 (− 10.7, 29.6) − 0.8 (− 3.7, 2.1) − 0.1 (− 0.4, 0.3) − 3.6 (− 13.2, 6.0) − 5.6 (− 13.5, 2.2) − 1.5 (− 8.2, 5.2) 0.1 (− 2.7, 3.0)
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size, however, in spite of all the limitations and shortcom-
ings, our study is the first in India to evaluate the effect of 
serum trans fatty acids on risk markers of cardiovascular 
disease.
Limitations
The study being cross-sectional in nature, could not 
derive a causative relationship between fatty acids and 
cardiovascular risk markers. The other limitation of our 
study is that dietary data was not collected which would 
have served as a validation for the fatty acids estimated in 
serum. Also the effect of fatty acids on various risk mark-
ers could have been evaluated after correcting with total 
energy intake.
Additional file
Additional file 1: Table S1. Percent content of fatty acids in serum.
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